Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use

Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use

ABSTRACT The comparative outcomes of specific aminoglycosides in cavitary type (fibrocavitary or cavitary nodular bronchiectatic type) Mycobacterium avium complex (MAC) pulmonary disease (PD) are unelucidated. We investigated the treatment outcomes with streptomycin or amikacin inclusion in the trea...

Full description

Bibliographic Details
Main Authors: Seong Min Kim, Yong Pil Chong, Hyun Joo Lee, Tae Sun Shim, Kyung-Wook Jo
Format: Article
Language:English
Published: American Society for Microbiology 2023-06-01
Series:Microbiology Spectrum
Subjects:
Mycobacterium avium complex
cavitary nodular bronchiectatic
fibrocavitary
culture conversion
streptomycin
amikacin
Online Access:https://journals.asm.org/doi/10.1128/spectrum.04741-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.04741-22

Similar Items